Publications
22
Citations
147
Est. group size
—
Recurring co-author estimate
Active years
8
Publishing since 2018
Shahin A. Saberi conducts clinical dermatology research spanning skin conditions, cutaneous side effects of cancer therapies (such as antibody-drug conjugates and immune checkpoint inhibitors), and treatment outcomes for conditions like hair loss and hidradenoma. A notable portion of the work also addresses medical education and health-system topics, including disability inclusion, opioid/naloxone training for students, and the effects of insurance reimbursement policy changes on dermatology practice. The research combines patient-focused clinical studies with reviews and health-policy analyses.
Publication activity was sparse through the late 2010s and then rose sharply, peaking in 2024, indicating a recently growing output.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Impact of 2021 <scp>CMS</scp> Changes on Pediatric, General Adult, and Micrographic Surgical Dermatology Encounter <scp>wRVUs</scp>
Pediatric Dermatology · 2025
- Response to Michelerio et al regarding “Antibody-drug conjugates: A review of cutaneous adverse effects”
Journal of the American Academy of Dermatology · 2025
- Substance Use and Pain Curriculum Innovation: Establishing a Student-Faculty Partnership for Curricular Change
Academic Medicine · 2025
- 63974 Comparison of RVUs for Pediatrics, General Adult, and Mohs Dermatology Visits Following 2021 CMS E/M Changes
Journal of the American Academy of Dermatology · 2025
- Navigating pruritus in patients with intellectual and developmental disabilities
Itch · 2025
- Antibody-drug conjugates: A review of cutaneous adverse effects
Journal of the American Academy of Dermatology · 2024
- Retrospective Analysis of US Litigations Involving Dermatologists From 2011 to 2022
Dermatologic Surgery · 2024
- Systemized approach to equipping medical students with naloxone: a student-driven initiative to combat the opioid crisis
BMC Medical Education · 2024
- Efficacy of Low-Dose Spironolactone for Hair Loss in Women.
PubMed · 2024
- Florid cutaneous morbilliform eruption in the setting of primary Epstein-Barr virus infection
JAAD Case Reports · 2024
- A New Horizon: The Promise of the National Institutes of Health’s Landmark Designation of Persons With Disabilities as a Population With Health Disparities
Annals of Internal Medicine · 2024
- Self-inflicted lesions in dermatology: The scars of self-harm
JAAD reviews. · 2024
- Clinical characteristics of patients with hidradenoma and hidradenocarcinoma: A multicenter retrospective review
Research Square · 2024
- 53727 Clinical characteristics of patients with hidradenoma and hidradenocarcinoma: A multicenter retrospective review
Journal of the American Academy of Dermatology · 2024
- Clinical characteristics of patients with hidradenoma and hidradenocarcinoma: A multicenter retrospective review
Archives of Dermatological Research · 2024
- Journal of the American Academy of Dermatology×5
- Neuropharmacology×2
- Journal of Pharmacology and Experimental Therapeutics×1
- Addiction Biology×1
- The AMA Journal of Ethic×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile